Microdosing may support moderate, sustainable weight loss of up to 10 pounds
If your goal is cosmetic weight loss at a normal BMI without a medical indication, this isnt the right program
CrossRef Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertension Benoit Aguado, Thomas Lacoste-Palasset, Grgoire Ruffenach, Fabrice Bauer, Laurent Savale, Marc Humbert, David Montani, Fabrice Antigny ERJ Open Research.2026
You may start leaving food on your plate
In type 2 diabetes, it often outperforms older therapies on both blood sugar and weight, which is why it is quickly becoming a backbone drug in highrisk metabolic patients. Better glycemic control cuts the risk of microvascular complications (eye disease, kidney damage, nerve damage) and macrovascular events (heart attack, stroke) over time. Fewer amputations, fewer cases of kidney failure, and fewer disabling strokes are core drivers of lost lifeyears and compressed healthspan that tirzepatide helps push back against. 3
Research on mice revealed a 7% reduction in body mass within just 10 days without impacting appetite